Nanox (NASDAQ: NNOX) se centra en liderar la transición mundial hacia una atención médica preventiva mediante una plataforma integral de servicios de salud y diagnóstico por imagen.
Nanox combina hardware de imagen asequible, soluciones avanzadas basadas en IA, software en la nube, acceso a radiología remota, soluciones tecnológicas para la salud y un mercado digital para permitir una detección más temprana, una mejor eficiencia clínica y un acceso más amplio a la atención.
La visión de Nanox es ampliar el alcance de la imagen médica, tanto dentro como fuera de los entornos hospitalarios tradicionales, ofreciendo una solución fluida e integral que abarca desde el escaneo hasta la interpretación y etapas posteriores. Al aprovechar la tecnología patentada de rayos X digitales, el análisis impulsado por IA y un enfoque clínico, Nanox tiene como objetivo mejorar la eficiencia de los flujos de trabajo de imágenes de rutina, respaldar la detección temprana de enfermedades y mejorar los resultados de los pacientes.
El ecosistema Nanox incluye Nanox.ARC, un sistema de tomosíntesis digital 3D multifuente, rentable y diseñado para ofrecer facilidad de uso y escalabilidad; Nanox.AI, un conjunto de algoritmos de IA diseñados para reforzar la interpretación de las imágenes de TC de rutina, permitiendo identificar indicios precoces que suelen asociarse a enfermedades crónicas; Nanox.CLOUD, una plataforma basada en la nube para la gestión segura de datos, almacenamiento y análisis avanzado de imágenes; Nanox.MARKETPLACE y USARAD Holdings, que proporciona acceso remoto a expertos en radiología y cardiología, y servicios integrales de telerradiología; y Nanox Health IT combina una profunda experiencia en tecnologías de atención médica con socios tecnológicos líderes para brindar soluciones de RIS, PACS, IA, dictado e infraestructura segura que agilizan los flujos de trabajo y respaldan una prestación de atención más segura y eficiente.
Al integrar tecnología de imágenes, inteligencia artificial, infraestructura en la nube, experiencia clínica, un mercado y tecnología de información de salud, Nanox busca reducir las barreras de adopción, mejorar la utilización y avanzar en la atención preventiva en todo el mundo.
Nuestro liderazgo
CEO & ACTING CHAIRMAN OF THE BOARD
Erez Meltzer, the Chief Executive Officer and the Acting Chairman of the Board. Prior to this role, he held the position of Chairman of the Board at Hadassah Medical Center in Israel for a duration of six years. Throughout his career, he has also assumed leadership roles in several prominent global companies, including Gadot Chemicals & Shipping Group, Africa Israel, Netafim, and Creo Scitex.
Ms. Kainan has served as a member of our board of directors since February 2021. Ms. Kainan established the forum for owners, chairpersons, and CEOs, she also serves as chairperson of the CFO Forum. Kainan serves as member in the Israeli Prime Minister’s Office committees, Board of Trustees of Bar Ilan University, and other NGOs. She served as a director of companies traded on the TASE. Kainan, co-authored the book “Israel – Island of Success”. Kainan holds an MBA from Tel Aviv University.
Michael Jackman currently serves as the CEO of 3DR Labs, a company that focuses on delivering AI and tech-enabled solutions and services to imaging departments and health systems . Prior to that Mr Jackman served as the COO of the Leidos (LDOS) health group from 2020 to 2024. Mr. Jackman was the CEO of Mach7 Technologies (M7T.AX), from 2017 to 2019, a company which focused on modernizing enterprise imaging. In addition, Mr. Jackman was a senior executive at GE Healthcare from 2011 to 2017, serving as the Americas Region CEO for Healthcare Digital (HCIT) and as the General Manager for Enterprise Imaging and care delivery solutions. Prior to 2011, Mr. Jackman held leadership roles for Carestream Health (President HCIT), iSOFT Health Group (EVP Operations), and Eastman Kodak (CTO of Healthcare division) and lastly at IBM, where he started his career in hardware and software and held several leadership positions. Mr. Jackman holds a BSEE in Electrical Engineering from University of Rhode Island, and an MBA in Business Administration from Nova University.
Mr. Suesskind served as the CFO of Teva Pharmaceuticals for 31 years, and as a director at numerous companies in the medical field. He is currently a director of NANO-X Imaging limited, IMED Infinity Medical, NEXTAR Chemopharma Solutions Ltd, SaNOtize R&D Corp, and The Jerusalem Foundation.
Erez Alroy for almost 20 years held various positions in the Shahal group, including 15 years as chief executive officer of SHL Telemedicine (SIX: SHLTN). Currently Mr. Alroy is a private investor and holds several board positions, including SHL Telemedicine Ltd. and Merhavia Holdings and Investments Ltd. (TASE), an investment firm that invests mainly in life science and healthcare companies. Mr. Alroy holds an MBA degree from the Hebrew University of Jerusalem.
Nehama Ronen, former Director General of the Israeli Ministry of Environmental Protection (1996-1999) and member of the Israeli Knesset (2001-2003), is currently the Chairperson of Maman Cargo Terminals & Handling Ltd. She has been actively involved in environmental and logistical leadership roles since then, including her executive chairmanship at ELA Recycling Corporations from 2005-2019.Additionally, Ms. Ronen has contributed to various boards, such as Tamar Petroleum Ltd., Dan Public Transportation, and Trendlines Group. With a strong commitment to environmental causes, she served on the board of Oil Refineries Ltd. (2008-2011) and Bank Hapoalim (2010-2015) , holds a B.A. in Education and History from Tel Aviv University and Beit Berl College, as well as an M.A. in Public Management from Haifa University. Ms. Ronen also graduated a Senior executive Program at the London Business School.
Dr. Kicska is an assistant professor in the thoracic section of the Department of Radiology at Harborview Medical Center in Seattle, Washington, where he also conducts research on digital chest tomosynthesis.
Department of Imaging. The Whittington Hospital London
Thomas (Tom) Dekle, Jr. Former Client Executive, IBM
General & Trauma Surgeon
Dr. Pickhardt is a Professor of Radiology at the University of Wisconsin Medical School, with more than 25 years of experience in the diagnostic radiology field.
Professor and Chairman of the Department of Medical Imaging at the University of Arizona.
Medical imaging executive with 25+ years of global leadership experience. Held senior roles at AGFA and Philips, specializing in imaging technologies and digital health transformation. Expert in bringing innovation to market and scaling customer-centric, tech-driven healthcare solutions.
Healthcare executive with over 25 years of leadership experience. Former GM of Nanox.AI and longtime CEO of Mor Research (Clalit Health Services). Expert in healthcare innovation, strategic partnerships, and global growth. Currently CEO of Laser-Team
Associate Director of the Cardiovascular Imaging Program, Brigham and Women’s Hospital Director of Cardiac Computed Tomography, and a preventative cardiologist.
CEO & ACTING CHAIRMAN OF THE BOARD
Erez Meltzer, the Chief Executive Officer and the Acting Chairman of the Board. Prior to this role, he held the position of Chairman of the Board at Hadassah Medical Center in Israel for a duration of six years. Throughout his career, he has also assumed leadership roles in several prominent global companies, including Gadot Chemicals & Shipping Group, Africa Israel, Netafim, and Creo Scitex.
General Manager of Source & Services Division & Head of Nanox USA
Mr. Dara has held senior executive roles in multinational companies, serving in his last position as President of MyCharge, and prior to that as VP of Business Development at Powermat, and VP and interim CEO at Wellsense.
EVP & Chief Marketing Officer
Ms. Aharon Cohen has over a decade of experience at global corporations, serving in her last position as CEO at Tempo-Heineken Cyprus, and prior to that as Division Manager and Marketing Manager at Tempo-Heineken Israel.
General Manager of ARC Division
Mr. Koren is a seasoned technological leader who served as General Manager and VP R&D at ReWalk Robotics, GM of RuggedCom, and VP R&D of Alvarion, leading the development of their WiMax mobile solution.
CHIEF LEGAL OFFICER (GC)
Prior to joining Nanox, Ms. Gofman Feler served as General Counsel at CollPlant Biotechnologies Ltd., a publicly traded biotechnology company. Marina holds an LL.B in Laws and a B.A in Economics from Tel Aviv University.
CHIEF CORPORATE RESOURCES
Prior to joining Nanox, Ms. Attias held the position of Chief of Staff at the Hadassah Medical Center for over 14 years. She holds a BA in Liberal Arts and Sciences from the Open University of Israel, and company Director and Corporate Officer training at the Reichman University.
General Manager of the AI Division
Prior to joining Nanox, Mr. Saban served as Vice President of Program Management at Parallel Wireless, COO of Mantis Vision, Director of Business Development at Samsung Strategy and Innovation Center (SSIC), and VP of R&D at Essence Group.
CFO
Mr. Nathanzon has extensive financial leadership experience with U.S. publicly traded companies, including several senior CFO and COO roles in medtech companies, as well as deep experience supporting growth, scale, and global operations.
Guy also brings medical technology experience, having served in senior leadership roles during periods of commercialization and expansion. He has previously served as the CFO of Scopio Labs, a medical technology company developing an AI-based diagnostic platform, and most recently was CFO of Valens Semiconductor, a New York Stock Exchange-listed company.
Senior Medical & Clinical Advisor
VP US Region
Medical Director, ARC Division
VP R&D Marketplace
Chief Executive Officer of USARAD Holdings Inc.
President& CMO, USARAD Holdings Inc.
Clinical Strategy, ARC Division
Chairman of Nanox Korea
Chief Medical Officer, US
VP R&D, ARC Division
VP IT & Cyber
Regional VP, Nanox HealthIT
Necesidad significativa no satisfecha
acceso relevante a la imagenología médica
Nuestro objetivo es construir una infraestructura global para la imagenología médica, combinando tecnologías potentes: nuestra fuente digital MEMS, soluciones de IA y soluciones de telerradiología para una solución integral de imagenología
El futuro es ahora
Portal del cliente